Chronic Conditions

Diabetes Obesity Type 2 Diabetes Heart Disease Asthma Diabetes Management Hypertension Heart Failure Kidney Disease Autoimmune Diseases

3 ARTICLES

last wk.

UK Regulator Probes Pancreatitis Cases Tied to GLP-1 Weight-Loss Therapies

Investigators are examining genetic risk factors after collecting almost 400 reports of pancreatic inflammation tied to GLP-1 drugs, ten of which proved fatal.

3 ARTICLES

last wk.

Liraglutide Pilot Study Halves Chronic Migraine Days, Paves Way for Randomized Trials

5 ARTICLES

3w ago

Liraglutide Cuts Chronic Migraine Days by More Than Half

3 ARTICLES

4w ago

Study Urges Geriatric Assessments for Growing Population of Older Breast Cancer Survivors

6 ARTICLES

4w ago

COVID-19 Vaccination Lowers Dialysis Need and Mortality in Kidney Injury Patients

13 ARTICLES

4w ago

Real-World GLP-1 Therapy Yields Lower Weight Loss, Spurs Tetra-Receptor Drug Research

5 ARTICLES

4w ago

UVA Artificial Pancreas Employs Digital Twin to Advance Diabetes Control

9 ARTICLES

last mo.

Omada Health Opens at $23 on Nasdaq Debut, Valued at $1.1 Billion

9 ARTICLES

last mo.

GLP-1 Agonists Tied to Higher Risk of Macular Degeneration and Rare Optic Neuropathy

5 ARTICLES

last mo.

AI foot scanner predicts heart failure admissions nearly two weeks in advance

5 ARTICLES

last mo.

Creon Shortage Forces UK Patients to Ration Doses and Skip Meals

4 ARTICLES

last mo.

AOK Study Finds Wide Regional Gaps and Persistent Benzodiazepine Overuse in German Nursing Homes

3 ARTICLES

last mo.

Skin barrier test could reshape diabetic foot ulcer closure standards

3 ARTICLES

last mo.

Biannual Zilebesiran Injections Significantly Lower Blood Pressure in Resistant Hypertension

3 ARTICLES

last mo.

ITV Documentary Renews Focus on UK’s Infected Blood Scandal as Legal Battles Resume

Particle.news

Chronic Conditions

UK Regulator Probes Pancreatitis Cases Tied to GLP-1 Weight-Loss Therapies

Liraglutide Pilot Study Halves Chronic Migraine Days, Paves Way for Randomized Trials

Liraglutide Cuts Chronic Migraine Days by More Than Half

Study Urges Geriatric Assessments for Growing Population of Older Breast Cancer Survivors

COVID-19 Vaccination Lowers Dialysis Need and Mortality in Kidney Injury Patients

Real-World GLP-1 Therapy Yields Lower Weight Loss, Spurs Tetra-Receptor Drug Research

UVA Artificial Pancreas Employs Digital Twin to Advance Diabetes Control

Omada Health Opens at $23 on Nasdaq Debut, Valued at $1.1 Billion

GLP-1 Agonists Tied to Higher Risk of Macular Degeneration and Rare Optic Neuropathy

AI foot scanner predicts heart failure admissions nearly two weeks in advance

Never miss stories about

Chronic Conditions

Creon Shortage Forces UK Patients to Ration Doses and Skip Meals

AOK Study Finds Wide Regional Gaps and Persistent Benzodiazepine Overuse in German Nursing Homes

Skin barrier test could reshape diabetic foot ulcer closure standards

Biannual Zilebesiran Injections Significantly Lower Blood Pressure in Resistant Hypertension

Stroke Cases Climb Among Young Adults; Women Bear Higher Burden

Record 166,360 Enrol in NHS Healthier You Diabetes Prevention Programme

NSW GPs to Diagnose and Prescribe ADHD Treatment in Major Health Reform

‘Ozempic Teeth’ Emerges as a Serious Dental Risk for Weight-Loss Drug Users

Doctors Remove 8,125 Gallstones from 70-Year-Old in Rare Gurugram Surgery

ITV Documentary Renews Focus on UK’s Infected Blood Scandal as Legal Battles Resume

Never miss stories about

Chronic Conditions